Atavistik Bio logo

Atavistik Bio

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$40M


Atavistik Bio is a biotech company developing precision allosteric therapeutics for oncology, leveraging proprietary screening technology and AI to discover new treatment sites on proteins or RNA.

Total Funding

$100M

Headquarters

Cambridge, USA

Founded

2021

Focus Areas

Biotech
Precision Allosteric Therapeutics
Oncology
Proprietary Screening Technology
AI-Enabled Drug Discovery
Protein/RNA Targets

Investors

The Column Group logo
Lux Capital logo
Nextech Invest logo